1024 Upadacitinib Treatment of Atopic Dermatitis Patients Leads to Reductions in Epidermal Hyperplasia and Cellular Infiltrates

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.1100
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Structure and Function of the Epidermal Barrier in Patients With Atopic Dermatitis – Treatment Options. Part One

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2018English

Cyclosporine in Patients With Atopic Dermatitis Modulates Activated Inflammatory Pathways and Reverses Epidermal Pathology

Journal of Allergy and Clinical Immunology
AllergyImmunology
2014English

Diagnosis and Treatment of Atopic Dermatitis.

Nippon Ika Daigaku Zasshi
1999English

Eosinophil Count and Serum Immunoglobulin E Levels in Atopic Dermatitis: Analysis of Upadacitinib Phase 2 Study Findings

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

The Atopic Dermatitis Itch Scale: Development of a New Measure to Assess Pruritus in Patients With Atopic Dermatitis

Journal of Dermatological Treatment
Dermatology
2020English

Future Trends in the Treatment of Atopic Dermatitis

Immunological Medicine
AllergyImmunology
2019English

Narrow-Band UVB Treatment in Atopic Dermatitis

Acta Dermato-Venereologica
DermatologyMedicine
2001English

Dupilumab for the Treatment of Atopic Dermatitis

Prescriber
Pharmacology
2018English

A Mild Topical Steroid Leads to Progressive Anti-Inflammatory Effects in the Skin of Patients With Moderate-To-Severe Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy